Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Document Type
Article
Publication Date
1-1-2021
Publication Title
Ther Adv Musculoskelet Dis
Keywords
washington; seattle; swedish
Abstract
Background: Involvement of the axial skeleton (sacroiliac joints and spine) is a relatively frequent manifestation associated with psoriatic skin disease, mostly along with involvement of peripheral musculoskeletal structures (peripheral arthritis, enthesitis, dactylitis), which are referred to as psoriatic arthritis (PsA). Data suggest that up to 30% of patients with psoriasis have PsA. Depending on the definition used, the prevalence of axial involvement varies from 25% to 70% of patients with PsA. However, there are currently no widely accepted criteria for axial involvement in PsA.Objective: The overarching aim of the Axial Involvement in Psoriatic Arthritis (AXIS) study is to systematically evaluate clinical and imaging manifestations indicative of axial involvement in patients with PsA and to develop classification criteria and a unified nomenclature for axial involvement in PsA that would allow defining a homogeneous subgroup of patients for research.
Design: Prospective, multicenter, multinational, cross-sectional study.
Methods and analyses: In this multicenter, multinational, cross-sectional study, eligible patients [adult patients diagnosed with PsA and fulfilling Classification Criteria for Psoriatic Arthritis (CASPAR) with musculoskeletal symptom duration of ⩽10 years not treated with biological or targeted synthetic disease-modifying anti-rheumatic drugs] will be recruited prospectively. They will undergo study-related clinical and imaging examinations. Imaging will include radiography and magnetic resonance imaging examinations of sacroiliac joints and spine. Local investigators will evaluate for the presence of axial involvement based on clinical and imaging information which will represent the primary outcome of the study. In addition, imaging will undergo evaluation by central review. Finally, the central clinical committee will determine the presence of axial involvement based on all available information.
Ethics: The study will be performed according to the ethical principles of the Declaration of Helsinki and International Council for Harmonisation Good Clinical Practice guidelines. The study protocol will be approved by the individual Independent Ethics Committee / Institutional Review Board of participating centers. Written informed consent will be obtained from all included patients.Registration: ClinicalTrials.gov ID: NCT04434885.
Clinical Institute
Orthopedics & Sports Medicine
Department
Orthopedics
Department
Rheumatology
Recommended Citation
Poddubnyy, Denis; Baraliakos, Xenofon; Van den Bosch, Filip; Braun, Jürgen; Coates, Laura C; Chandran, Vinod; Diekhoff, Torsten; van Gaalen, Floris A; Gensler, Lianne S; Goel, Niti; Gottlieb, Alice B; van der Heijde, Désirée; Helliwell, Philip S; Hermann, Kay Geert A; Jadon, Deepak; Lambert, Robert G; Maksymowych, Walter P; Mease, Philip; Nash, Peter; Proft, Fabian; Protopopov, Mikhail; Sieper, Joachim; Torgutalp, Murat; and Gladman, Dafna D, "Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)." (2021). Articles, Abstracts, and Reports. 5743.
https://digitalcommons.providence.org/publications/5743
